This tissue is then examined histologically and molecularly to confirm the presence of cancer, determine the subtype, assess hormone receptor status (e.g., estrogen receptor, progesterone receptor), and evaluate HER2 (human epidermal growth factor receptor 2) expression. This evidence concerns the gene ERBB2 and cancer.